2020 TAG ANNUAL REPORT PROGRESS IN THE FIGHT For Better Treatment, Prevention, a Vaccine, and a Cure for HIV, Tuberculosis, and Hepatitis C Virus BOARD PRESIDENT LETTER

June 2021

Dear Friend of TAG: This month marks the 40th anniversary of the U.S. government’s first reports of the emergence of what later became known as AIDS. Over those four decades, 76 million people became infected with HIV, and over 33 mil- lion have died from it. Thanks to research and activism, more than 26 million of the world’s 38 million people living with HIV are receiving Your support lifesaving treatment. Though unacceptable gaps remain, the prog- ress since — spurred in no small part by TAG’s informed, targeted, has been central and tireless activism — has been remarkable. to TAG’s success over Over 40 individual antiretroviral treatments (ART) have been ap- the past three decades, proved. From no treatment at all, ART has evolved from complicated “and particularly regimens with spotty efficacy and brutal side effects to simple pills during this past year or even monthly injections that durably reduce HIV to undetectable levels. Highly effective prevention options are available. Two individ- of overwhelming uals are known to have been cured. Thanks to TAG and our partners uncertainty. pushing for high standards, community engagement, and health justice, I watched the transformation of HIV infection from a frequently fatal condition among my friends to what is now a preventable and treatable condition — as long as prevention, therapy, care, and information are accessible. As the HIV epidemic changes over time, and new pandemics continue to emerge, I’ve been amazed and proud at how TAG continues to evolve while remaining true to its activist roots. We partner with the most affected commu- nities in the U.S. and around the world. After TAG accelerated the development of effective ART in the mid-1990s, we moved on to catalyze advocacy movements for the two deadliest coinfections of people with HIV — tubercu- losis and hepatitis C. And in 2020, we began applying our unique science-based and community-driven voice, as well as the lessons learned over the past nearly three decades, to COVID-19. It’s been such an honor to lead TAG’s Board of Directors over the past 25 years. I’m pleased to announce some changes to TAG’s Board of Directors. I am passing the Board President’s baton to Rob Lennon, who brings his brilliant leadership and dedication to TAG’s mission. The highly capable Mrinal Vikram is now our Secretary. Laura Morrison remains TAG’s steadfast Treasurer. I remain forever a part of TAG’s community, committed to advancing TAG’s vital work to end pandemics and the inequitable structures that allow them to flourish. Your support has been central to TAG’s success over the past three decades, and particularly during this past year of overwhelming uncertainty. I know you’ll find inspiration in reading about the amazing work the TAG staff and partners accomplished in spite of all the challenges during 2020. I hope you will continue — as I will — to support TAG so we can accelerate the end of these pandemics once and for all.

Yours in the fight,

Barbara Hughes President Emeritus, Board of Directors

2 • 2020 TAG ANNUAL REPORT 2020 RESEARCH IN ACTION AWARDS

We held our annual Research in Action Awards virtually for the first time on Thursday, November 19, 2020. Journalist and activist Ann Northrop was our host, and the multitalented Rachel York treated our audience to amazing performances. Dr. Jonathan LaPook of CBS News moderated a compelling roundtable discussion Wwith panelists Dr. Wafaa El-Sadr, Dr. Trip Gulick, and Annette Gaudino. Our wonderful honorees were Dr. Anthony S. Fauci, National Nurses United, Wakefield, and Sharon Stone. Mark Harrington talked about TAG’s many achievements in this difficult year, and our event chair Bob Bronzo made a moving appeal. Cameos, many of them from previous RIAA honorees, lit up the screen: Amanda Lugg, Peter Staley, Lynda Dee, Greg Millett, Dr. Mary T. Basset, David France, Alan Cumming, Judith Light, Matthew Lopez, Jon Cohen, Kevin Goetz, and Barbara Hughes. You can relive the wonderful evening here.

Anthony S. Fauci, M.D. Bonnie Castillo, National Nurses United

And so, to my dear All along the way friends“ and colleagues with we“ have spoken up for whom I have worked with at our Black, Brown, and TAG, thank you very much Indigenous patients for this award. It means a who have been hit great deal to me. Together, hard by this pandemic, we have accomplished especially given the much, and for this, we racial injustice that can feel proud and is inseparable from energized for the inevitable health care injustice in challenges ahead. this country. ” ”

Sharon Stone Wakefield I’m here to scream for This award joy“ for all the work that from“ TAG touches you’re doing at TAG, and me most deeply, I’m here to say, I could not however, because be more humbled, more our association did honored, or more devoted not begin with the to this journey in my life to current pandemic; end HIV/AIDS in my lifetime we go back and to continue to work decades. We have with the Treatment Action gone through the Group in whatever way wars together. they’ll have me. ” ”

2020 TAG ANNUAL REPORT • 3 2020 TAG ANNUAL REPORT PROJECT UPDATES

HIV PROJECT

• TAG’s Basic Science, Vaccines, and Cure Project • TAG’s “Landscape Analysis of HIV Cure-Related Director Richard Jefferys published an analysis of Clinical Research” was published in the Journal of HIV cure-related clinical trials, highlighting important Virus Eradication, and a companion community issues such as the continuing underrepresentation of summary was made available on our website. women. Richard spoke to the New York Times about • ANEA launched a new website and revised the the second individual to be cured of HIV. executive summary for the coalition’s community • TAG hired Edric Figueroa as the first ACT NOW: roadmap to end HIV in the U.S. END AIDS (ANEA) Coalition Coordinator. With • TAG hired our first HIV Community Engagement ANEA, we supported diverse community groups in Officer,Abraham Johnson, MPH, to strengthen Alabama, Dallas, Los Angeles, Memphis, and New community involvement with the HIV Vaccine Trials Orleans to fund and carry out local work to end the Network, Black AIDS Institute, and the COVID HIV epidemics there. Prevention and Vaccine Trials Network (CoVPN). • HIV Project Director Jeremiah Johnson and Richard • Edric, speaking for ANEA, participated in a panel published results of a survey on community at the Presidential Advisory Council on HIV/AIDS perspectives on the future of HIV prevention trials for (PACHA) meeting on the future of the federal the HIV Vaccine Trials Network (HVTN). ending HIV Initiative. ANEA provided a robust • TAG published four TAG HIV pipeline reports, along transition memo to the Biden-Harris Administration with its firstCOVID-19 pipeline. detailing the need for a human rights approach • TAG waged a successful campaign with partners and community leadership in the incoming to ensure the participation of people with HIV in administration’s HIV response. the phase III COVID-19 vaccine trials sponsored by • TAG, in partnership with the Black AIDS Institute and Moderna and Pfizer. the HIV Vaccine Trials Network, launched the first We • With allies, TAG launched a call to end racism and The People Research Cohort to train advocates from underrepresented U.S. communities to participate in over-policing in NYC, called on New York’s Board of HIV prevention research advocacy. Health to declare these a public health emergency,

and deplored the politically motivated resignation of NYC Health Commissioner Dr. Oxiris Barbot.

As a long-time activist, Thank you, TAG, for I cannot underestimate the leading the fight to end HIV, importance of TAG’s work in tuberculosis, and hepatitis “our world. “C, and now COVID-19, for everyone around the world. – Amanda Lugg, RIAA 2020 – Rachel York, RIAA 2020

4 • 2020 TAG ANNUAL REPORT TB PROJECT

• Advocacy by TAG’s TB team, including members • TAG published, in PLOS ONE, a comprehensive of Guideline Development Groups, resulted in review of public, foundation, and corporate strong recommendations for improved diagnostics investment in developing bedaquiline, the first and treatment regimens by the WHO. To help new TB drug in a new class approved in fifty years, activists unpack these updated guidelines and hold showing that the public sector (mainly the U.S. governments accountable for ensuring access to government) invested between 160 percent and 500 higher diagnostic and treatment standards, the TB percent more than the company in this breakthrough team launched An Activist’s Guide to Tuberculosis drug, now the cornerstone of drug-resistant TB Diagnostic Tools and An Activist’s Guide to treatment. This landmark article is among the most Treatment for Drug-Resistant Tuberculosis. in-depth, comprehensive peer-reviewed articles showing the evidence for public versus private • TAG secured a major win for human rights when a United Nations body issued a progressive General investments in developing any drug. Leveraging Comment on the right to science incorporating TAG’s these findings,TAG and the TB CAB called for J&J, the manufacturer, to reduce the drug’s price to $1/ input. day. • TAG and civil society partners in 10 countries advocated for access to the best TB preventive • TAG’s TB and policy teams launched a policy therapy. TAG and partners in India, Thailand, and brief showing how tools, concepts, capacity, and France successfully resisted spurious attempts by Big infrastructure established through years of public Pharma to patent two decades-old medicines used to investments in TB R&D have informed COVID-19 prevent TB (isoniazid and rifapentine) by publishing research and responses. an Access Roadmap and Patent Landscape on • New studies for which TAG advocated over the past the two drugs with statements supporting patent decade showed that drug-sensitive TB can now be oppositions. cured in four rather than six months in both adults • TAG, with the Médecins Sans Frontières (MSF) and children. A TAG-led community advisory board Access Campaign, expanded the scope and reach played a leading role in disseminating these results. of the Time for $5 Campaign, a global civil society • The TB team published four pipeline report chapters, movement calling on Cepheid to reduce the prices reviewing recent progress in the development of of Xpert rapid tests for TB, HIV, HCV, COVID-19, and new TB diagnostics, treatments, preventive therapy, other conditions to $5. and vaccines. With the Stop TB Partnership, TAG • TAG refreshed and diversified the membership of its published Tuberculosis Research Funding Trends, Global Tuberculosis Community Advisory Board (TB 2005–2019, the 15th in a series of influential reports CAB), adding members from India, Kenya, Moldova, tracking global funding for TB research. Peru, Ukraine, and Zimbabwe, and convened annual • The policy and TB teams coordinated advocacy for meetings with key TB research and product sponsors TB research and program investment by the U.S. virtually. Congress, promoting increased R+D investment and preserving TB program funding in Indiana and New York.

Whenever there’s a new epidemic, like Ebola, and now COVID, AIDS activists step up to the plate. We’re the first to do it, TAG is the first to do it. “ – Peter Staley, RIAA 2020

2020 TAG ANNUAL REPORT • 5 TAG PROJECT UPDATES

POLICY 2020 HCV PROJECT

• TAG’s policy team achieved funding increases to • TAG convinced the President’s Emergency Plan for many of the organization’s priority issues in fiscal AIDS Relief (PEPFAR) to expand its country guidance year (FY) 2021 appropriations, in the midst of the for viral hepatitis including HCV testing, treatment, COVID-19 pandemic, nationwide demonstrations and cure for people coinfected with HIV and HCV in calling for long-overdue racial justice, and a hotly PEPFAR focus countries. disputed election cycle. Among agencies receiving • TAG HCV Project Director Bryn Gay collaborated on increased federal funding for fiscal year 2021 were the first meeting between harm reductionists, USAID’s Global Accelerator to End TB (+$9 million), community representatives, and new officials at the NIH HIV research (+$14 million), CDC viral hepatitis Georgian Ministry of Health, resulting in the research (+$500,000), and the CDC’s Ending the HIV establishment of a ministry-community steering Epidemic Initiative (+$35 million). committee to implement treatment guideline • TAG’s Senior Government Relations and Policy changes, community recommendations, and action Officer Lizzy Lovinger spoke at the Presidential plans to reduce or eliminate HCV infection in the Advisory Council on HIV/AIDS (PACHA), expressing Republic of Georgia. Plans for sustaining TAG’s strong support for increased HIV research engagement have been paused due to COVID-19. funding due to COVID-19 disruptions, the need • Bryn and TAG Policy Strategy Director Annette for rigorous ethical standards, and the dangers of Gaudino published an issue brief, in English and political interference in research. French, on difficult-to-treat hepatitis C subtypes • With AVAC and HealthGAP, TAG condemned the found in sub-Saharan Africa and its diaspora. unwise U.S. move to withdraw its membership and • The HCV and TB teams joined the Unitaid-funded funding support for the WHO. LONGEVITY project to support community • Lizzy was elected co-chair of the Tuberculosis engagement in clinical trials development of long- Roundtable coalition, where she will lead and acting treatments for HCV, TB, and malaria. TAG facilitate federal and global TB advocacy initiatives. held preliminary discussions with the Medicines Lizzy participated in several meetings with the Patent Pool and the LONGEVITY project’s Biden-Harris transition team to discuss global health commercial partner Tandem Nano Ltd to assess community requests. alternative incentives (other than exclusivity in rich countries) in the related voluntary licensing • TAG’s policy team collaborated with TAG’s HIV, agreements, which would expand future generics HCV, and TB projects to publish a landmark series access. of policy briefs on how investments in HIV, TB, and HCV research have profoundly benefited • Bryn catalyzed diagnostics advocacy and informed a and accelerated science’s ability to respond to community wishlist in Malaysia, leading to the COVID-19. adoption of numerous policy changes, such as free HCV testing and treatment, including in some harm • Due to the relentless advocacy of TAG’s Annette reduction sites. Gaudino over many years, in September 2020, New York State removed prior authorization requirements • Bryn spoke on HCV diagnostics literacy and for HCV cures for NYS Medicaid, correctional, and community engagement work at a World Hepatitis privately insured individuals, allowing combination Day webinar and made recommendations on new therapy cures for hepatitis C virus (HCV) and making indicators at the first World Health Organization it easier for these New Yorkers to be cured of HCV (WHO) Viral Hepatitis Elimination Validation infection. Building on this win, five additional states meeting. are now removing these barriers to HCV cures.

6 • 2020 TAG ANNUAL REPORT TAG PROJECT UPDATES

• Bryn and Annette launched the 2020 HCV Pipeline • Columbia University professor Wafaa El-Sadr and Report, which won praise from the Director of the Mark coordinated a letter by the COVID Working CDC Division of Viral Hepatitis. Group urging the city to establish safe spaces for • Bryn, Mark Harrington, and Suraj Madoori met with vulnerable individuals with presumed or diagnosed the new WHO Head of HIV, Viral Hepatitis, and mild/moderate COVID-19 disease who are unable STI Division, Dr. Meg Doherty, about TAG’s HCV to self-isolate at home due to crowded quarters priorities, where they gained commitments to wider or inability to self-care. This effort influenced NYC community consultations and succeeded in getting Council legislation mandating housing for homeless our recommended community representatives persons with COVID-19. accepted for the WHO Key Populations Guidelines • TAG produced a statement defending the World meeting. Health Organization from funding cuts proposed by • Bryn provided a comprehensive and detailed the U.S. president. orientation with our new HCV Community • Annette Gaudino co-led efforts to secure the Engagement Officer Joelle Dountio Ofimboudem release of incarcerated persons from New York State to support the LONGEVITY project’s community jails and prisons to protect them from ongoing engagement activities, particularly around long- unacceptable exposure to SARS-CoV-2 and later acting formulations for HCV. worked to secure access to COVID-19 vaccines for • With the TB Team, Bryn and Joelle managed this population. consultants’ preparations of a patent landscape and • Bryn presented a poster on the right to science access strategy report for long-acting glecaprevir/ and access to COVID-19 technologies at the pibrentasvir (Mavyret for HCV), rifapentine, isoniazid, International AIDS Society COVID-19 Conference. delamanid, and bedaquiline for TB. The report will • Lizzy Lovinger delivered TAG’s testimony at the be launched in 2021 and will inform community October 22 meeting of the FDA’s Vaccine and workshops. Related Biologic Products Advisory Committee meeting to support FDA’s maintenance of high COVID-19 RESPONSE standards for oversight and regulatory review of potential vaccines for COVID-19 in the face of political interference. • In March 2020, TAG rapidly and smoothly shifted its internal operations and advocacy work in response • Annette served as the public health lead in to the global COVID-19 pandemic while continuing coalition with legal advocates, contributing her to advance existing work in HIV, HCV, and TB expertise from the initial drafting through 11th hour research and advocacy. Jeremiah Johnson and Mark amendment negotiations, persuading the NYS Harrington cofounded a virtual New York–focused legislature to pass and Governor Cuomo to sign into COVID-19 Working Group, which several TAG law the first and only contact tracing confidentiality staff participated in, in partnership with community law, barring law enforcement and immigration partners and with support from Columbia University authorities from accessing identifying information School of Social Work and generous gifts to TAG collected in the course of the COVID-19 response. from long-time supporters. • Bryn Gay drafted global principles on access to COVID-19 medicines, technologies, and innovation, adapted them for the U.S. context and in a letter to the G20 health ministers, and promoted them while mentoring a “squad” of activists in the Salk Advocacy Innovation Lab, a network of over 300 activists in 29 countries demanding a free and accessible vaccine for all.

2020 TAG ANNUAL REPORT • 7 2020 TAG FINANCIALS

Balance Sheet

Assets 2020 2019 Cash and cash equivalents $1,571,364 $1,610,906 Unconditional Promises to Give 2,465,371 496,981 Accounts receivable 1,252 7,583 Prepaid expenses and other current assets 50,247 37,208 Donated artwork 470,239 492,739 Security deposit 72,463 72,463 Property and equipment - net 18,477 18,580 Total Assets $4,649,413 $2,736,460

Liabilities and Net Assets Liabilities Accounts payable and accrued expenses $48,767 $38,603 Loan Payable 214,717 Deferred rent 18,613 33,362 Total Liabilities 282,097 71,965 Net Assets Without donor restrictions 1,402,831 1,537,543 With donor restrictions 2,964,485 1,126,952 Total Net Assets 4,367,316 2,664,495 Total Liabilities and Net Assets $4,649,413 $2,736,460

Statement of Cash Flows 2020 2019 Cash Flows from Operating Activities Increase (decrease) in net assets $1,702,821 ($590,354) Adjustments to reconcile increase (decrease) in net assets to net cash used by operating activities: Depreciation 9,776 9,547 (Increase) decrease in: Unconditional promises to give (1,968,390) 719,890 Accounts receivable 6,331 (6,444) Prepaid expenses and other assets (13,039) (5,614) Donated artwork 22,500 (53,000) Increase (decrease) in: Accounts payable and accrued expenses 10,164 13,207 Deferred rent (14,749) (9,158) Net Cash Used by Operating Activities (244,586) 78,074

Cash Flows from Investing Activities Acquisition of property and equipment (9,673) (1,399) Net Cash Used by Investing Activities (9,673) (1,399)

Cash Flows from Financing Activities Proceeds from loan payable 214,717 - Net decrease in cash and cash equivalents (39,542) 76,675 Cash and cash equivalents, beginning of year 1,610,906 1,534,231 Cash and Cash Equivalents, End of Year $1,571,364 $1,610,906

8 • 2020 TAG ANNUAL REPORT Statement of Activities 2020 Without Donor With Donor Restrictions Restrictions Total Revenue and Other Support Contributions $511,667 $3,979,681 $4,491,348 Fundraising benefit events 170,555 - 170,555 Less: Direct benefit expenses Donated artwork, goods and services 336 - 336 Art sales, net of cost of goods sold 1,700 - 1,700 Other income 25,978 - 25,978 Interest income 737 - 737 Net assets released from restrictions 2,142,148 (2,142,148) -

Total Revenue and Other Support 2,853,121 1,837,533 4,690,654

Expenses Program Services HIV Program 964,172 - 964,172 Hepatitis C Virus Program 234,426 - 234,426 Tuberculosis Program 1,277,362 - 1,277,362 Total Program Services 2,475,960 - 2,475,960

Supporting Services Management and general 360,015 - 360,015 Fundraising 151,858 - 151,858 Total Expenses 2,987,833 - 2,987,833

Increase (decrease) in net assets (134,712) 1,837,533 1,702,821 Net assets, beginning of year 1,537,543 1,126,952 2,664,495 Net Assets, End of Year $1,402,831 $2,964,485 $4,367,316

Summary of 2020 FunctionalSummary Expenses of 2020 Functional Expenses

Management & Administration 12% 5% Fundraising

Program Services 83%

2020 TAG ANNUAL REPORT • 9 2020 TAG CONTRIBUTORS

$100,000 or more William Shea and Frank R. Selvaggi Noel E.D. Kirnon and Michael D. Paley The Aurum Institute Barry C. Skovgaard and Marc Wolinsky Latino Commission on AIDS Bill and Melinda Gates Foundation John Voelcker Michael K. Longacre Hopewell Fund Weil, Gotshal & Manges LLP Jeff Meleski and Steve Markov Fred Hutchinson Cancer Research Center Jeff Mendoza and Dr. Chuck Sklar Stop TB Partnership hosted by UNOPS $2,500 to $4,999 National Coalition of STD Directors University of Nebraska Medical Center Columbia University Donesh Olyaie ViiV Healthcare John F. Duane and Mary E. Northridge Otsuka Novel Products GmbH The Gendal Family Foundation Eddie Pelto $50,000 to $99,999 Dr. Michael F. Giordano Daniel Ptacek Broadway Cares / Equity Fights AIDS Global Health Strategies Walter Rieman Merck & Co. Judith Harrington Paul Sack Veterans Affairs Medical Center of Mark Harrington Dr. Bruce Schackman and Edward K. Sikov Washington, DC Megan Harrington and Jonathan Andrew C. Schirrmeister III Creighton Evan Schwartz and Robert Fitterman $25,000 to $49,999 Robert C. Henry H.A. ‘Hal’ Sedgwick The Debs Foundation: Richard A. and Barbara F. Hughes Francesco Sedita and Doug Yacka Barbara Knowles Debs; Nick Debs Fannie and Stephen Kahn Charitable The Sigal Family Foundation: David Sigal David Gold Foundation and NY State Senator Brad Hoylman Housing Works Winston B. Layne Peter Staley M·A·C VIVA GLAM Fund Dr. J. Michael McCune III and Dr. Karen Henry Thaggert Open Society Foundations Kaye Smith-McCune Emily Tillman Screen Engine / ASI Rachel B. Tiven and Seth M. Marnin $10,000 to $24,999 Mark M. Sexton and W. Kirk Wallace Donn Vecchie-Campbell The Calamus Foundation The Estate of Samuel J. Silling Margaret Rose Vendryes Joseph Evall and Richard M. Lynn Audrey Sokoloff and Tim Hosking Paul Forrest Williams, Jr. Annie Bennett Glenn Fund of The Mrinal Vikram and Kevin Finnegan Wistar Institute BEAT-HIV Winston Salem Foundation The Andrew David Zacks Foundation Tim Wuliger Robert W. Lennon and Mark Gilrain Max von Zuben Médecins du Monde $1,000 to $2,499 National TB Controllers Association AbbVie $500 to $999 Jim Aquino Acadiana Cares $5,000 to $9,999 Alejandro and Ivy Kwan Arce Moisés Agosto amfAR, The Foundation for AIDS Research Katherine C. Ash and Thomas M. Ash III Richard Aguiar Sam Avrett and David Barr Jack M. Battaglia ATAC / AIDS Treatment Activists Coalition Michael Becker and Tee Scatuorchio Beth Israel Deaconess Medical Center I4C AVAC / AIDS Vaccine Advocacy Coalition Celeste B. Cooper CAB Ian and Luann Bailey / Vivid Coffee Federation of Protestant Welfare Bob Bronzo Margot and Robert J. Bazell Agencies Karen Bronzo and Jefferson Rabb Michael Beltran and Tim Ford David France Marisa Cardinale Frank Bua and Scott Carroll Kevin and Neil Goetz Susan Chun Steven J. and Denise Chickery Hauser & Wirth Marc E. Elovitz Joe Ciancaglini Marta Heflin Foundation Jonathan Fine Benson Cohen Ambassador James C. Hormel and Catherine Garzio and Martin Mattes Corey Family Trust: Lawrence Corey, MD Michael P.N. Hormel Judy and Steven Gluckstern Robert N. Croonquist Erica Lessem Christina and Kenneth Hecht Scott Dainton Robert Monteleone Brian Hodge Arianne Z. Dar / New Ground Fund of Laura A. Morrison IAVI / International AIDS Vaccine Initiative Marin Community Foundation Roche Jameel Jiwani Hon. Thomas K. Duane Jordan Roth and Richie Jackson Tigist Kassahun and Lizzy Lovinger EATG / European AIDS Treatment Group

10 • 2020 TAG ANNUAL REPORT Gene Falk Prof. Richard Buxbaum and Catherine Jenna Young Steven M. Frank and Dr. Elizabeth S. Hartshorn Vicki Zubovic Powell Richard Cardillo Jennifer J. Furin, MD, PhD Jill Casid and Anna Campbell plus donations from an additional Bryn Gay Stephanie and Walter Cowles 298 generous contributors, including Anonymous gifts Aaron Glick Dick Dadey

New York State Assembly Member Lynda M. Dee, Esq. We would also like to thank those who Deborah J. Glick John Deyling gave generously to TAG as part of Harry Greenwald and Babette Krolik Peter Morris Dixon campaigns hosted by Act Blue Charities, Roy M. ‘Trip’ Gulick, MD PayPal Charitable Giving, and Network Joy Episalla and Carrie Yamaoka for Good for Facebook fundraising J. Drew Hodges and Peter Kukielski Andrew Friedman campaigns. TAG received funds by Michael T. Isbell Ron Goldberg and Joe Chiplock participation in the Amazon Smile Richard Jefferys program, and also received generous Rodney and Idan Gould Employee Matching Funds from several Rebecca Jordan-Young Craig Greiwe business giving platforms. TAG would Burt R. Lazarin Dr. Polly F. Harrison like to thank artist Keith Mayerson and the Red Hot Organization for generous Kate Lear and Dr. Jonathan LaPook Paula Hartstein and Jonathan Levin in-kind donation of goods to support the David C. Levine Paul D.C. Huang 2020 Research in Action Awards event Kelsey Louie, Executive Director, GMHC Larry Iannotti that benefitted TAG. Saurav Madoori Karyn Kaplan and Cindy Kaplan Vincent Martin and Jason Kirk Paul E. Kennedy Joseph McConnell and Erik Haagensen Sung Woon Kil Carole D. Mitnick, ScD Susan Leimsider Mirla N. and George J. Morrison Jay Leitz Sally Morrison and Tobias Corser Claire Lennon Mylan Inc. Krista Martel / The Well Project NASTAD / National Alliance of State and Dr. Brian P. and Laura J. McKenna Territorial AIDS Directors Albert S. Messina National Financial Services Kristin Milot NMAC / National Minority AIDS Council Fraser D. ‘Skip’ Mooney Ann Northrop Glenn Nuotio Richard Parsons Kathleen O’Leary Robert H. Remien Jason Osher and Richard Schubel Greig Sargeant Pam Parker Jason Schreiber Diane Parrish Sarah F. and Roy E. Schutzengel Donna M. Pauldine Andrew Shih Rob and Kate Previti Virginia Shubert and David Sipress Mark Quigley Monte Steinman Sara Rafsky UCSF DARE Collaboratory CAB Candis L. and Daniel S. Ramelli Paolo Danilo Vicino Sheila Reeves Wendy Wertheimer Clifford Richter Jeffrey H. Schmitt and Michael A. Petrilli $250 to $499 Jane Silver Stuart Anthony Paula Silver Nick Azrack John B. Steever, MD John Barone Keith S. Tobin, MD Danielle Berz Cash van Halder Barbara and Richard Boxer Dorrit Walsh Rory Bruer Thomas P. Wilczak and Steven R. Quinkert Ama Burnham Peter Yorgin

2020 TAG ANNUAL REPORT • 11 About TAG TAG Limited Art Editions 2021 STAFF Treatment Action Group (TAG) is an Each year, at its Research in Action EXECUTIVE DIRECTOR: independent, activist, and community- Awards, TAG presents a new, limited Mark Harrington based research and policy think edition work of art. This year, our DEPUTY EXECUTIVE DIRECTOR: tank committed to racial, gender, edition was Homage to America’s Erica Lessem and LGBTQ+ equity; social justice; Doctor, Anthony S. Fauci by Keith TB PROJECT OFFICER: and liberation, fighting to end HIV, Mayerson. The package also included David Branigan tuberculosis (TB), and hepatitis C virus other now sold-out elements, and was (HCV). supported by the generosity of Red HCV COMMUNITY ENGAGEMENT OFFICER: TAG catalyzes open collective action by Hot and the Marta Heflin Foundation. Joelle Dountio Ofimboudem affected communities, scientists, and Many TAG art editions, including a few of artist prints of our 2020 edition, ANEA COORDINATOR: policymakers to ensure that all people Edric Figueroa living with or impacted by HIV, TB, or are available for sale to the public. All proceeds benefit TAG’s work. If you’re TB PROJECT CO-DIRECTOR: HCV — especially communities of color Mike Frick and other marginalized communities interested in purchasing an edition or DIRECTOR OF POLICY experiencing inequities — receive life- learning more, detailed information can be found at STRATEGY: saving prevention, diagnosis, treatment, https://www. Annette Gaudino care, and information. treatmentactiongroup.org/support- us/ limited-art-editions/. HCV PROJECT DIRECTOR: We are science-based activists working Bryn Gay to expand and accelerate vital research FINANCE MANAGER: and effective community engagement Christopher George with research and policy institutions DIRECTOR OF FINANCE AND for an end to the HIV, TB, and HCV OPERATIONS: pandemics. Sabrina Guerrero-Morris

BASIC SCIENCE, VACCINES, AND CURE PROJECT DIRECTOR: Support TAG Richard Jefferys

Over the past three decades, TAG has HIV COMMUNITY ENGAGEMENT been central to the fight against HIV, OFFICER: Abraham Johnson HCV, and TB. In 2020, we continued our vital core work to end HIV, HCV, HIV PROJECT DIRECTOR: Jeremiah Johnson and TB while also applying our expertise to the COVID-19 pandemic. GRANT OFFICER: Jason Kirk A robust response based on science 2021 BOARD OF DIRECTORS and driven by community priorities is SENIOR GOVERNMENT Robert W. Lennon more crucial than ever. PRESIDENT: RELATIONS AND POLICY SECRETARY: Mrinal Vikram OFFICER: Elizabeth Lovinger Make a gift to TAG and help us TREASURER: Laura Morrison advocate for the needs of all people Jim Aquino U.S. AND GLOBAL HEALTH affected by HIV, HCV, TB, and Nick Debs POLICY DIRECTOR: Suraj Madoori COVID-19. Joy Episalla Kevin Goetz ADMINISTRATOR: Roy Gulick, M.D. Support TAG today: https:// Joseph McConnell Jameel Jiwani treatmentactiongroup.salsalabs.org/ Richard Lynn, Ph.D., M.P.H. TB PROJECT CO-DIRECTOR: spring2021. Robert Monteleone Lindsay McKenna Eddie Pelto COMMUNICATIONS MANAGER: Does your organization have a matching David Sigal Dorrit Walsh gifts program? Don’t miss your chance to make a gift that keeps on giving. BOARD PRESIDENT EMERITUS: Barbara Hughes Complete and send us your company’s matching gift form to double your TAG Board and staff thank Barbara contribution’s impact! Hughes for her decades of selfless service and wise leadership. We love you, Barbara.

12 • 2020 TAG ANNUAL REPORT www.treatmentactiongroup.org

90 Broad Street, Suite 2503 New York, NY 10004 Tel 212.253.7922

[email protected]

TAG is a nonprofit, tax-exempt 501(c)(3) organization. EIN 13-3624785